Article

Structural Proteomics-Driven Targeted Design of Favipiravir-Binding Site in The RdRp of SARS-CoV-2 Unravels Susceptible Hotspots and Resistance Mutations

2021-05-20

Abstract excerpt

Favipiravir is a broad-spectrum inhibitor of viral RNA-dependent RNA polymerase (RdRp) currently being used to manage COVID-19 in several countries. By acting as a substrate for RdRp, favipiravir gets incorporated into the nascent viral RNA and prevents strand extension. A high mutation rate of SARS-CoV-2 RdRp may facilitate antigenic drift as an answer to the host immune response, thereby generating resistance of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d0568366-212d-5a46-b80e-302ebedb4164
DOI: 10.20944/preprints202105.0492.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Structural Proteomics-Driven Targeted Design of Favipiravir-Binding Site in The RdRp of SARS-CoV-2 Unravels Susceptible Hotspots and Resistance MutationsDOI 10.20944/preprints202105.0492.v1Read

Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.Semantic proximity Read

Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.Semantic proximity Read

Rational Design of the Remdesivir Binding Site in the RNA-dependent RNA Polymerase of SARS-CoV-2: Implications for Potential ResistanceSemantic proximity Read

Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes.Semantic proximity Read

High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistanceSemantic proximity Read

Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerasesSemantic proximity Read

A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2.Semantic proximity Read

Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesisSemantic proximity Read

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design ChallengeSemantic proximity Read

Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.Semantic proximity Read

Structural basis of SARS-CoV-2 polymerase inhibition by FavipiravirSemantic proximity Read

Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug DiscoverySemantic proximity Read